This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit May 13, 2015

Home   About   Join Us   Annual Conference   The Voice   Career Center   Resources   Education Plus  

 

The great success and enduring dilemma of cervical cancer screening
NPR
Cervical cancer, which still kills about 4,000 American women every year, is almost entirely preventable. Proper screening can catch early warning signs that could lead to cancer without the right treatment. But how often women should get screened and which tests should be used has been hotly debated by women, doctors and medical researchers for the past decade. The American College of Physicians weighed in with guidelines, endorsed by the American College of Obstetricians and Gynecologists, that aim to reduce unnecessary screening. They say that no women should be getting annual Pap tests, at any age.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


ASCT 2015 Conference
ASCT
We had an excellent turnout of over 100 attendees at the 2015 Annual Conference in Nashville, Tennessee! Participants enjoyed interactive and informative sessions, including 3 lectures by our Bob Gay Lecture Series speaker, R. Marshall Austin, M.D., Ph.D. We would like to congratulate all of our award winners! Banan Abuhard from the cytotechnology program at the University of Texas MD Anderson Cancer Center School of Health Professions was the 1st place winner of the Warren R. Lang Student Award, followed by Ryan Granger who took 2nd place and Aaron Beaver who placed 3rd. Fern Miller was the recipient of the 2015 Holmquist Cytotechnologist Achievement Award. The President's Award was given to Vivian Pijuan-Thompson and Mary Ann Friedlander was the winner of the Allen Achievement in Writing Award. We look forward to seeing everyone next year at the 2016 ASCT Annual Conference in Ft. Lauderdale, FL!
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


UPCOMING EVENTS

Date Event Location More information
May 20,
2015
Type 1 and Type 2 Cervical Cancers: Some Cervical Cancers are More Difficult to Prevent with Cervical Screening Your PC


Dr. R. Marshall Austin, M.D., Ph.D.
Professor of Pathology, Director of Cytopathology University of Pittsburgh School of Medicine Magee-Womens Hospital of UPMC; Pittsburgh, PA
More info
Register

Available for 6 months after subscribing

Quality Assessment Center (QAC) Cell Blocks Basics Workbench

Your PC

Details

Available for 6 months after subscribing

Quality Assessment Center (QAC) Document Control for Cytopathology Workbench

Your PC

Details

Available for 6 months after subscribing

Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench

Your PC

Details


INDUSTRY NEWS


Physicians show poor adherence to cervical cancer screening guidelines
HealthDay via Oncology Nurse Advisor
The indications for cervical cancer screening in asymptomatic average-risk women are described in a best practice advice article published online April 30 in the Annals of Internal Medicine. George F. Sawaya, M.D., from the University of California in San Francisco, and colleagues describe the indications for cervical cancer screening in asymptomatic, average-risk women, aged 21 years or older.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


HPV screening alone may miss cervical cancer
Medscape (free login required)
Human papillomavirus screening used on its own can miss cervical cancer, according to a study that found that more cases were detected when it was used in combination with cytology. The study was published online April 10 in Cancer Cytopathology. In a "real-world" population of more than 250,000 women, 526 cases of confirmed cervical cancer were detected. HPV results were negative in 18.6 percent of these women, Pap test results were negative in 12.2 percent, and both test results were negative in 5.5 percent.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Frequent aspirin use reduces risk of cervical cancer by nearly half
Medical Xpress
Long-term and frequent use of aspirin is associated with significantly decreased risk of cervical cancer, according to a study led by researchers at Roswell Park Cancer Institute and published in the Journal of Lower Genital Tract Disease. Aspirin use was associated with a 47 percent reduced risk of cervical cancer among frequent users — those who used aspirin seven or more times a week, regardless of duration — and 41 percent reduced risk among long-term frequent users — those with five or more years of frequent use.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


By 2020, the most common HPV-related cancer will affect men
The Huffington Post
While currently recommended for both boys and girls, the HPV vaccine was initially marketed — and is still thought of — as a way to protect young women and girls from cervical, vaginal and vulvar cancer. Boys, it's been commonly thought, should be vaccinated primarily to benefit herd immunity and any future female partners. But a new analysis from researchers at the Princess Margaret Cancer Center in Toronto, Canada, points out that boys who get the vaccine receive important protection as well, not only against genital warts, but against HPV strains that cause oropharyngeal (mouth and throat) cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


HPV: 1.1 million more women started vaccine after ACA passed
Medscape (free login required)
Passage of the Affordable Care Act, which extended health coverage to more young adults and erased co-payments for certain preventive treatments, was associated with an additional 1.1 million women aged 19 to 25 years initiating the three-dose human papillomavirus vaccine, according to a study. Brandy J. Lipton, Ph.D., a senior service fellow in the Office of Analysis and Epidemiology, National Center for Health Statistics, Hyattsville, Maryland, and Sandra L. Decker, Ph.D., a consultant in the Office of Analysis and Epidemiology, National Center for Health Statistics, report their findings in an article published in the May issue of Health Affairs.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Missed an issue of ASCT Viewpoint? Click here to visit the ASCT Viewpoint archive page.


Study: Benefits of HPV vaccine can be seen in high school girls
Los Angeles Times
Years before the HPV vaccine prevents women from getting cervical cancer, it protects them against genital warts and cervical dysplasia, new research suggests. A study of more than 260,000 teen girls in Ontario, Canada, finds that those who received all three doses of Gardasil were 44 percent less likely than their unvaccinated peers to be diagnosed with cervical dysplasia during their high school years. It also appears that the vaccine reduced the risk of genital warts by 43 percent, researchers reported in the journal Pediatrics.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Quadrivalent HPV vaccine provides early benefit in adolescent girls
Healio
Girls aged between 14 and 17 years experienced early beneficial effects with the quadrivalent HPV vaccine; therefore, offering additional justification for not delaying vaccination, according to new study findings. Researchers observed decreases in cervical dysplasia and possible decreases in the occurrence of anogenital warts.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


CMS proposes covering Pap smear/HPV testing for cervical cancer
AAFP
A little more than a year ago, the AAFP prodded CMS to update its coverage of screening for cervical cancer for women ages 30 to 65. The AAFP noted at the time that CMS had the authority to add additional preventive services to Medicare coverage. Fast forward 12 months and it's obvious that the Academy's persistence — along with its knowledge of Medicare rules and regulations — paid off.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MORE NEWS


RFA therapy shows promise in treating pancreatic cancer
By Dr. Afsaneh Motamed-Khorasani
Pancreatic cancer has been ranked as the fourth-leading cause of cancer-related mortality in the West. A number of advances in surgical techniques have been applied in the treatment strategy for this cancer. However, none of these improvements was able to make a noticeable difference in the five-year survival rate, which makes it a pressing priority to come up with a novel effective strategy that can have a bigger impact on the survival rate of pancreatic cancer. One of the adjunctive treatments highly studied has been radiofrequency ablation, or RFA.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Many Americans aren't getting cancer screenings
TIME
A new federal report shows a high number of Americans are not undergoing recommended screenings for colorectal, breast and cervical cancers. New data released from the Centers for Disease Control and Prevention shows that in 2013, which is the latest data available, screening for the three cancers either dropped lower than previous rates or showed no improvement. The numbers show that around 20 percent of women said they were not up to date with cervical-cancer screenings, and a quarter of women were not getting recommended breast cancer screening. Overall, two in five adults had not had their recommended colorectal screening.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

ASCT Viewpoint
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Esther Cho, Content Editor, 469.420.2671   
Contribute news

This edition of ASCT Viewpoint was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
April 22, 2015
April 8, 2015
March 25, 2015
March 11, 2015



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063